theophylline has been researched along with Arteriosclerosis Obliterans in 26 studies
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FERNANDEZBLANCO, E | 1 |
DEFERNANDEZBLANCO, JF | 1 |
AGUSTINARZENO, J | 1 |
FEUSER, J | 1 |
LUCZAK, S | 1 |
BUECHNER, H | 1 |
Buccellato, C | 1 |
Di Lorenzo, GD | 1 |
Kostka-Trabka, E | 1 |
Grodzińska, L | 1 |
Dembińska-Kieć, A | 1 |
Basista, M | 1 |
Telesz, E | 1 |
Bielawiec, M | 3 |
Kiersnowska-Rogowska, B | 1 |
Myśliwiec, M | 2 |
Perzanowski, A | 2 |
Lingetti, M | 1 |
Policicchio, D | 1 |
Ciarimboli, M | 1 |
Di Grezia, F | 1 |
Lingetti, E | 1 |
Policicchio, F | 1 |
Keller, L | 1 |
Landi, A | 1 |
Bársony, J | 1 |
Chwistecki, K | 1 |
Bochenek, W | 1 |
Lawiński, M | 1 |
Lasso, M | 1 |
García Merlo, S | 1 |
Alvarez, C | 1 |
Hansteen, V | 1 |
Lorentsen, E | 1 |
Kiersnowska, B | 1 |
Lukjan, H | 1 |
Korfel, B | 1 |
Rogowski, F | 1 |
Dowzyk, W | 1 |
Brücknerová, O | 1 |
Cascio, F | 1 |
Szilvási, I | 1 |
Molnár, G | 1 |
De Gregorio, G | 1 |
Scaffidi, L | 1 |
Arcoraci, A | 1 |
Wittenburg, H | 1 |
Kusztos, D | 2 |
Bereczky, M | 1 |
Fono, J | 1 |
Mahr, H | 1 |
Pontenagel, M | 1 |
Evers, E | 1 |
EL Hakim, S | 1 |
Franke, R | 1 |
Wortmann, F | 1 |
Serradimigni, A | 1 |
Bory, M | 1 |
Poggi, L | 1 |
Audier, M | 1 |
Greif, S | 1 |
Molino, N | 1 |
Belluardo, C | 1 |
Catalano, S | 1 |
Blasi, A | 1 |
Licciardello, M | 1 |
2 trials available for theophylline and Arteriosclerosis Obliterans
Article | Year |
---|---|
[Diprophyllinum prolongatum (Polfa, Cracow) in the treatment of arteriosclerosis obliterans of the lower limbs].
Topics: Administration, Oral; Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Delayed-Ac | 1983 |
[Drug therapy of arterial circulatory disorders with Lioftal].
Topics: Arteries; Arteriosclerosis Obliterans; Blood Coagulation Tests; Cholesterol; Diabetic Angiopathies; | 1969 |
24 other studies available for theophylline and Arteriosclerosis Obliterans
Article | Year |
---|---|
[7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
Topics: Arteriosclerosis; Arteriosclerosis Obliterans; Cholesterol; Coronary Disease; Humans; Intracranial A | 1963 |
[A CONTRIBUTION TO COMPLAMIN TREATMENT].
Topics: Arteriosclerosis Obliterans; Biomedical Research; Cardiovascular Diseases; Coronary Disease; Drug Th | 1964 |
[EXPERIENCES WITH THE MEDICAL TREATMENT OF ARTERIOSCLEROSIS OBLITERANS].
Topics: Arteriosclerosis Obliterans; Collateral Circulation; Drug Therapy; Geriatrics; Niacin; Nicotinic Aci | 1964 |
[Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
Topics: Aged; Arteriosclerosis Obliterans; Dextrans; Diabetic Angiopathies; Female; Gangrene; Humans; Infusi | 1967 |
The behaviour of the platelet-leukocyte aggregation in thrombotic conditions.
Topics: Adult; Aged; Arteriosclerosis Obliterans; Blood Coagulation; Coronary Disease; Drug Therapy, Combina | 1975 |
[Metabolic therapy of atherosclerosis].
Topics: Aged; Arteriosclerosis; Arteriosclerosis Obliterans; Choline; Cytidine Diphosphate Choline; Drug The | 1979 |
The use of Xavin infusions in obliterating peripheral arterial disorders.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Drug Evaluation; Female; Huma | 1975 |
[Assessment of the action of Sadamine Polfa and Mydocalm Richter preparations as based on photoplethysmography].
Topics: Arteriosclerosis Obliterans; Humans; Piperidines; Plethysmography; Propiophenones; Raynaud Disease; | 1975 |
[Long-term hypolipemic therapy in arteriosclerosis obliterans].
Topics: Aged; Anticholesteremic Agents; Arteriosclerosis Obliterans; Diet Therapy; Dietary Fats; Humans; Hyp | 1976 |
Vasodilator drugs in the treatment of peripheral arterial insufficiency.
Topics: Adult; Aged; Aminophylline; Angiotensin II; Arteriosclerosis Obliterans; Drug Evaluation; Female; Fo | 1974 |
The influence of some drugs on platelet aggregation and adhesion.
Topics: Administration, Oral; Adult; Aged; Arteriosclerosis Obliterans; Coronary Disease; Densitometry; Drug | 1972 |
[Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
Topics: Administration, Oral; Adult; Aged; Arteriosclerosis Obliterans; Evaluation Studies as Topic; Female; | 1973 |
[Experiences with the treatment of peripheral vascular diseases with Xavin].
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Female; Humans; Intermittent Claudic | 1973 |
[Hemokinetic and metabolic action of 7-2-(3-pyridyl-methylamino)-ethyl-theophylline nicotinate as a basis of medical treatment of chronic obliterating peripheral arteriopathy].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis Obliterans; Blood Pressure; Chronic Disea | 1973 |
Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
Topics: Arteriosclerosis Obliterans; Blood Circulation Time; Drug Evaluation; Humans; Leg; Muscles; Regional | 1973 |
[Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
Topics: Arteriosclerosis Obliterans; Cardiovascular System; Cerebrovascular Disorders; Humans; Intracranial | 1971 |
[Experience with Complamin in peripheral circulation disorders].
Topics: Aged; Arteriosclerosis Obliterans; Diabetic Angiopathies; Extremities; Female; Humans; Male; Middle | 1969 |
[Complamine in obliterating peripheral circulatory disorders].
Topics: Aged; Arteriosclerosis Obliterans; Female; Humans; Male; Middle Aged; Nicotinic Acids; Theophylline; | 1970 |
[Effect of bencyclane in obliterative arterial diseases].
Topics: Aged; Arteriosclerosis Obliterans; Blood Circulation; Cerebrovascular Disorders; Cycloheptanes; Diab | 1970 |
[Therapy of venous and arterious circulation disorders using Melilotus].
Topics: Arteriosclerosis Obliterans; Coumarins; Humans; Oils; Plant Extracts; Resins, Plant; Rutin; Theophyl | 1971 |
[Treatment of arterial circulation disorders with complamin and volume substitutes in intravenous continuous drip infusion].
Topics: Aged; Arteriosclerosis Obliterans; Blood Pressure; Femoral Artery; Humans; Infusions, Parenteral; Ma | 1968 |
[Medical treatment of acute arterial obliteration in the limbs].
Topics: Acute Disease; Adult; Aged; Arteriosclerosis Obliterans; Drug Synergism; Female; Fibrinolytic Agents | 1968 |
[Fluidifying action of 3(methyl-oxyethylamino)-2 oxypropyl-theophylline nicotinate (Vedrin)].
Topics: Arteriosclerosis Obliterans; Humans; Theophylline; Thromboembolism; Thrombosis | 1966 |
[Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Body Temperature; Diabetic Angiopathies; Ethylenediamines; | 1966 |